$8.67
-1.15-11.71%
Last update: Nov 5, 4:00 PM
OptimizeRx Corp
OPRXNASDAQ
The average analyst price target for OptimizeRx is $12.08, 39.3% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $5 to $23. The latest change came on Sep 29, 2026, when B. Riley Securities raised its price target on OptimizeRx from $10 to $11 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
